Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SQUEEZE Trial: A Trial to Determine Whether Septic Shock Reversal is Quicker in Pediatric Patients Randomized to an Early Goal Directed Fluid Sparing Strategy vs. Usual Care

NCT03080038 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.

NCT NCT03080038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03080038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SQUEEZE Trial: A Trial to Determine Whether Septic Shock Reversal is Quicker in Pediatric Patients Randomized to an Early Goal Directed Fluid Sparing Strategy vs. Usual Care
Lead sponsor
McMaster University
Phase
Not applicable
Overall status
Completed
Start date
March 6, 2017
Completion date
December 31, 2021
Enrollment
406 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock